Type 2 Diabetes Trial, By Invitation NCT05055804 Sponsor: XP Technology, LLC Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, By Invitation

NCT05055804
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with type 1 or type 2 diabetes.
  • People between the ages of 25 and 65.
  • Both men and women are welcome to apply.
  • People from a variety of ethnic backgrounds are encouraged to participate.
  • People who are able to attend 2 visits scheduled within a 2 to 4 week period, with each visit lasting up to 1 to 2 hours.
  • People who have availability during daytime hours for their visits.
  • People who are able to have one blood draw from a vein and up to 4 finger-prick blood tests at each visit.
  • People who are able to fast (avoid eating or drinking) for at least 6 hours before their first visit.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are currently taking illegal drugs or misusing prescription drugs.
  • People who have taken part in another research study within the last 30 days.
  • People who have had a blood transfusion or significant blood loss within the last 14 days.
  • People who have been diagnosed with Sickle Cell Anaemia.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
XP Technology, LLC
Registry
ClinicalTrials.gov
Start date
11 August 2021
Est. completion
1 October 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Standard OTC Glucose, A1C & Laboratory Results in Comparison to ELG Device During Fasting Event; Standard OTC Glucose, A1C & Laboratory Results in Comparison to ELG Device During Non-Fasting Event

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov